Bernhard J. Hering

Papers

Total Citations

H-Index

About

Bernhard J. Hering is a pioneering figure in the field of islet transplantation and a leading authority on cellular therapies for diabetes. His research has fundamentally advanced the understanding and clinical application of islet cell replacement, with a major focus on improving transplant outcomes for patients with severe, brittle type 1 diabetes. Hering’s most cited work includes a landmark study on a novel, minimally invasive surgical approach—the laparoscopic and da Vinci robot-assisted total pancreaticoduodenectomy combined with intraportal islet autotransplantation. This contribution, cited over 20 times, demonstrated a critical technical innovation for safely harvesting islets from patients with chronic pancreatitis, thereby preventing surgically-induced diabetes. His broader impact is reflected in his role as a key investigator in the Clinical Islet Transplantation Consortium, where his work has helped establish islet transplantation as a viable, life-changing therapy. With a career spanning decades, Hering’s research has not only pushed the boundaries of surgical and immunological science but has also directly improved the quality of life for countless patients, cementing his legacy as a transformative leader in regenerative medicine and transplant surgery.